DOT Drug Testing & 49 CFR Part 40: Employer Guide

LabX Diagnostic Systems · July 25, 2026

If any of your employees perform safety-sensitive work in transportation, your drug and alcohol program is not optional and it is not yours to design freely. It is governed by 49 CFR Part 40, the U.S. Department of Transportation regulation that dictates exactly how specimens are collected, tested, reviewed, and reported. Getting a single step wrong can invalidate a result or expose you to liability, so it pays to understand the framework before you build your program.

Who is covered by 49 CFR Part 40

Part 40 applies to "safety-sensitive" employees regulated by a DOT operating administration: commercial drivers under the Federal Motor Carrier Safety Administration (FMCSA), aviation workers (FAA), rail (FRA), transit (FTA), pipeline (PHMSA), and maritime crews (USCG). If a role fits one of those categories, testing must follow the federal rule precisely — you can read the current regulation in full on the Electronic Code of Federal Regulations, and the DOT's own plain-language guidance lives at the Office of Drug and Alcohol Policy and Compliance (ODAPC).

The federal 5-panel

DOT testing uses a fixed 5-panel: marijuana (THC), cocaine, amphetamines (including methamphetamine and MDMA), opioids (including certain semi-synthetics such as hydrocodone, hydromorphone, oxycodone, and oxymorphone), and phencyclidine (PCP). You cannot add or remove analytes from a DOT test. If you want broader coverage for non-regulated roles, that is a separate non-DOT employer screening program — see our breakdown of DOT vs non-DOT testing for how the two coexist.

Collection and chain of custody

DOT collections use the federal Custody and Control Form (CCF) and a strict, documented chain of custody. Specimen integrity checks, temperature reads, and split-specimen handling are all prescribed. Because the paperwork is unforgiving, the discipline you build here also protects your non-regulated tests — we cover the principles in why chain of custody matters.

The six DOT testing events

  • Pre-employment — required before an employee first performs safety-sensitive duties.
  • Random — unannounced, drawn from a scientifically valid selection at agency-set minimum rates.
  • Reasonable suspicion — triggered by trained supervisor observation of specific, articulable signs. Our manager's guide to reasonable-suspicion testing walks through documentation.
  • Post-accident — under defined thresholds after a qualifying crash.
  • Return-to-duty — after a violation, following the SAP process, and always observed.
  • Follow-up — an individualized, unannounced schedule after return to duty.

MRO review is mandatory

Every non-negative DOT laboratory result must be verified by a Medical Review Officer, a licensed physician who checks for a legitimate medical explanation before a result is reported to the employer. This is not a formality — it is what separates a defensible program from a lawsuit. Learn what the MRO actually does in our post on the MRO's role. For general workplace program design, the SAMHSA Drug-Free Workplace resources and the FMCSA drug and alcohol testing program pages are the authoritative starting points.

Common employer mistakes

  • Treating medical marijuana or CBD as a valid excuse. Under DOT, a legitimate THC positive stands regardless of a state card.
  • Mixing DOT and non-DOT specimens on one form. They must be kept administratively separate.
  • Skipping supervisor training before relying on reasonable-suspicion testing.
  • Using an unqualified lab. DOT specimens must go to a HHS-certified laboratory.

Random testing and the FMCSA Clearinghouse

Random testing is often the hardest event to administer correctly. Selections must be truly random, drawn from the entire pool of covered employees at the agency-mandated minimum annual rate, and spread throughout the year — you cannot cluster them in one quarter or exempt a favored employee. For motor carriers, the program is tied to the FMCSA Drug and Alcohol Clearinghouse, a federal database that records violations and mandatory queries. Employers must run pre-employment and annual queries and report actual-knowledge violations. The FMCSA drug and alcohol testing program resources explain the query and reporting obligations in detail.

Return-to-duty and the SAP process

An employee who tests positive or refuses a test is immediately removed from safety-sensitive duty and cannot return until completing the return-to-duty (RTD) process overseen by a Substance Abuse Professional (SAP). The SAP evaluates the employee, recommends education or treatment, and — only after a face-to-face follow-up evaluation — clears them for a directly observed RTD test. A tailored, unannounced follow-up testing schedule (at least six tests in the first year, and potentially for up to five years) follows. Skipping or shortcutting these steps is one of the most common and costly compliance failures. Because RTD and follow-up tests must be observed, they pair naturally with LabX's observed collection options and documented chain of custody, and every non-negative still routes through MRO review.

DOT drug testing FAQs

Is medical marijuana ever allowed under DOT?

No. A verified THC positive stands under DOT rules regardless of a state medical-marijuana card or a CBD explanation, because marijuana remains federally prohibited for safety-sensitive employees.

Can I use my regular 10-panel for DOT drivers?

No. DOT testing is a fixed federal 5-panel with prescribed procedures. You can run a separate 10-panel for non-regulated roles, but the two programs must be kept separate.

Who reviews a DOT positive?

A Medical Review Officer verifies every non-negative before it reaches the employer.

How LabX supports compliant programs

LabX Diagnostic Systems is a CLIA-certified (#10D2067145), COLA-accredited laboratory in Tampa, Florida. We confirm presumptive positives by LC-MS/MS, coordinate MRO review, and support both observed collections and convenient mail-in options through TeleTest. Employers can manage panels, results, and billing from one employer dashboard, and existing clients can sign in to review results securely. Ready to build a defensible program? Order kits or explore our full test menu to get started.

Keep reading

Explore our Test Menu → More from the Insights